相关实验视频

Updated: Sep 16, 2025

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

允许性心脏毒性和确定先前暴露于类人环素的类人环素风险

Richard J Travers¹, Nicholas Camarda², Iris Z Jaffe²

¹Division of Hematology/Oncology, Tufts Medical Center, Boston, Massachusetts, USA; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts, USA.

JACC. Case reports

|July 11, 2025

概括

人环素有效治疗血液癌症,但风险心脏损伤,特别是累积剂量. 这一案例凸显了在必要时使用 antracyclines 重新治疗心脏毒性风险的管理方面的挑战.

科学领域:

在瘤学瘤学.
心脏病学心脏病学
药理学药理学是指药理学的学科.

背景情况:

人环素对于治疗血液性恶性瘤至关重要.
心脏毒性是 antracyclines 的一个显著的剂量依赖的副作用.
关于非多克索鲁比类人类循环素的剂量等价性以及以前使用德克斯拉佐克桑对风险分层的影响存在不确定性.

研究的目的:

为了解决在治疗不同配方的患者中计算累积的环素剂量的挑战.
探索风险分层和监测心脏毒性的策略,在需要重复暴露的病人中进行心脏毒性监测.
介绍一个案例研究,说明多学科的决策,关于重复的Anthracycline治疗在一个患者之前心脏毒性问题.

主要方法:

综述了有关 antracycline 心脏毒性和剂量等效性的现有文献.
一个患有急性髓性白血病复发的患者的病例介绍,需要重新治疗.
讨论反复暴露于 antracycline 的风险-益处分析和心脏保护策略.

主要成果:

这一案例凸显了由于不同配方的不同,管理累积的环素剂量的复杂性.
发现了风险分层的挑战,特别是关于先前使用德克斯拉的挑战.
多学科讨论强调仔细考虑再治疗的风险和益处.

结论:

准确的累积剂量评估对于管理antracycline心脏毒性至关重要.
需要进一步的研究来澄清剂量等价性和先前德克斯拉佐治疗的影响.
个性化策略对于监测和预防反复接受 antracycline 治疗的患者的心脏毒性至关重要.

关键词:

急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.环素是一种环素.心脏有毒性心脏有毒性允许的毒性允许的毒性幸存者幸存者幸存者

更多相关视频

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

相关概念视频

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...